Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite
Crossref DOI link: https://doi.org/10.1186/1939-4551-8-S1-A20
Published Print: 2015
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Compalati, Enrico
Rinciani, Antonio
Text and Data Mining valid from 2015-01-01
Version of Record valid from 2019-07-26
License valid from 2015-01-01